Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Chinese Patent Office
Chubb
Dow
McKesson
Express Scripts
Cantor Fitzgerald
US Department of Justice
Johnson and Johnson

Generated: September 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020122

« Back to Dashboard

NDA 020122 describes NIPENT, which is a drug marketed by Hospira Inc and is included in one NDA. It is available from one supplier. Additional details are available on the NIPENT profile page.

The generic ingredient in NIPENT is pentostatin. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pentostatin profile page.
Summary for 020122
Tradename:NIPENT
Applicant:Hospira Inc
Ingredient:pentostatin
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 020122
Medical Subject Heading (MeSH) Categories for 020122
Suppliers and Packaging for NDA: 020122
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NIPENT pentostatin INJECTABLE;INJECTION 020122 NDA Hospira, Inc. 0409-0801 0409-0801-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0801-01) > 5 mL in 1 VIAL, SINGLE-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10MG/VIAL
Approval Date:Oct 11, 1991TE:APRLD:Yes

Expired US Patents for NDA 020122

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hospira Inc NIPENT pentostatin INJECTABLE;INJECTION 020122-001 Oct 11, 1991 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Medtronic
US Department of Justice
QuintilesIMS
Julphar
Johnson and Johnson
Mallinckrodt
Chinese Patent Office
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.